These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2202193)

  • 21. Analysis of programmed stimulation methods in the evaluation of ventricular arrhythmias in patients 20 years old and younger.
    Silka MJ; Kron J; Cutler JE; McAnulty JH
    Am J Cardiol; 1990 Oct; 66(10):826-30. PubMed ID: 2220580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators.
    Olshansky B; Hahn EA; Hartz VL; Prater SP; Mason JW
    Am Heart J; 1999 May; 137(5):878-86. PubMed ID: 10220637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
    Farré J; Cabrera JA; Romero J; Rubio JM
    Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients.
    Fananapazir L; Tracy CM; Leon MB; Winkler JB; Cannon RO; Bonow RO; Maron BJ; Epstein SE
    Circulation; 1989 Nov; 80(5):1259-68. PubMed ID: 2805263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents.
    Belhassen B; Shapira I; Shoshani D; Paredes A; Miller H; Laniado S
    Circulation; 1987 Apr; 75(4):809-16. PubMed ID: 3829343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanisms determining sudden death. A cooperative study of 69 cases recorded using the Holter method].
    Leclercq JF; Coumel P; Maison-Blanche P; Cauchemez B; Zimmermann M; Chouty F; Slama R
    Arch Mal Coeur Vaiss; 1986 Jun; 79(7):1024-33. PubMed ID: 3096225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation.
    Reiffel JA
    Am J Cardiol; 1996 Aug; 78(4A):34-40. PubMed ID: 8780327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators.
    Am J Cardiol; 1993 Aug; 72(3):280-7. PubMed ID: 8342505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation.
    Wever EF; Hauer RN; Oomen A; Peters RH; Bakker PF; Robles de Medina EO
    Circulation; 1993 Sep; 88(3):1021-9. PubMed ID: 8353864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of spontaneous recurrent ventricular arrhythmias detected by electrogram-storing defibrillators in sudden cardiac death survivors with no inducible ventricular arrhythmias at baseline electrophysiologic testing.
    Zaim S; Zaim B; Rottman J; Mendoza I; Nasir N; Pacifico A
    Am Heart J; 1996 Aug; 132(2 Pt 1):274-9. PubMed ID: 8701887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association between electrocardiogram characteristics and long-term outcome in patients with idiopathic ventricular fibrillation].
    Wang J; Jia YH; Mao KX; Chen XH; Zhao YJ; Wei W; Zhang YM; Zhu XY; Tao Y; Hua W; Zhang S; Chu JM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):970-4. PubMed ID: 21215223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sudden cardiac arrest associated with early repolarization.
    Haïssaguerre M; Derval N; Sacher F; Jesel L; Deisenhofer I; de Roy L; Pasquié JL; Nogami A; Babuty D; Yli-Mayry S; De Chillou C; Scanu P; Mabo P; Matsuo S; Probst V; Le Scouarnec S; Defaye P; Schlaepfer J; Rostock T; Lacroix D; Lamaison D; Lavergne T; Aizawa Y; Englund A; Anselme F; O'Neill M; Hocini M; Lim KT; Knecht S; Veenhuyzen GD; Bordachar P; Chauvin M; Jais P; Coureau G; Chene G; Klein GJ; Clémenty J
    N Engl J Med; 2008 May; 358(19):2016-23. PubMed ID: 18463377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical intracardiac electrophysiologic testing: technique, diagnostic indications, and therapeutic uses.
    Hammill SC; Sugrue DD; Gersh BJ; Porter CB; Osborn MJ; Wood DL; Holmes DR
    Mayo Clin Proc; 1986 Jun; 61(6):478-503. PubMed ID: 3520168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators.
    Greene HL
    Am J Cardiol; 1993 Nov; 72(16):70F-74F. PubMed ID: 8237833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators.
    Pires LA; May LM; Ravi S; Parry JT; Lal VR; Nino CL
    Am J Cardiol; 2000 Mar; 85(6):725-8. PubMed ID: 12000047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.